Home About us Current issue Back issues Submission Instructions Advertise Contact Login   

Search Article 
  
Advanced search 
 
Saudi Journal of Kidney Diseases and Transplantation
Users online: 1721 Home Bookmark this page Print this page Email this page Small font sizeDefault font size Increase font size 
 


 
Table of Contents   
LETTER TO THE EDITOR  
Year : 2013  |  Volume : 24  |  Issue : 4  |  Page : 793-794
Renal transplantation in idiopathic thrombocytopenic purpura


1 Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, Dr H L Trivedi Institute Of Transplantation Sciences (ITS)-Smt Gulabben Rasiklal Doshi and Smt Kamlaben Mafatlal Mehta Institute off Kidney Diseases and Research Centre (IKDRC), Civil Hospital Campus, Asarwa, Ahmedabad - 380 016, Gujarat, India
2 Department of Nephrology and Clinical Transplantation, Dr H L Trivedi Institute Of Transplantation Sciences (ITS)-Smt Gulabben Rasiklal Doshi and Smt Kamlaben Mafatlal Mehta Institute off Kidney Diseases and Research Centre (IKDRC), Civil Hospital Campus, Asarwa, Ahmedabad - 380 016, Gujarat, India

Click here for correspondence address and email

Date of Web Publication24-Jun-2013
 

How to cite this article:
Kanodia KV, Vanikar AV, Shah PR, Trivedi H L. Renal transplantation in idiopathic thrombocytopenic purpura. Saudi J Kidney Dis Transpl 2013;24:793-4

How to cite this URL:
Kanodia KV, Vanikar AV, Shah PR, Trivedi H L. Renal transplantation in idiopathic thrombocytopenic purpura. Saudi J Kidney Dis Transpl [serial online] 2013 [cited 2019 Oct 20];24:793-4. Available from: http://www.sjkdt.org/text.asp?2013/24/4/793/113890
To the Editor ,

Chronic kidney disease (CKD) in idiopathic thrombocytopenic purpura (ITP) is uncommon. Poor platelet function secondary to uremic coagulopathy adds up to the risk of transplantation surgery. Kidney transplantation may be challenging in such patients for the platelet dysfunction due to the original disease. We report a case of kidney transplantation with ITP and the preparation for this event.

A 27-year-old woman with CKD was evaluated for kidney transplantation from her mother aged 56 years and HLA 3/6 match as potential donor. The patient underwent splenectomy three years earlier for ITP of 25 years duration resistant to steroids and IV immunoglobulins (IvIg). Her hypertension was controlled with calcium channel and beta blockers and hypothyroidism was controlled with thyroxine. On examination, she was pale with a pulse rate of 100/min and a blood pressure of 130/80 mmHg. Systemic examination was unremarkable except for splenectomy scar. Her hemoglobin was 7.4 g/dL, total leucocyte count was 13,200/cmm, platelet count (PC) was 35,000/cmm, urine albumin was 300 mg/24 h and microscopy was 10-12 red blood cells/ high-power field. Serum creatinine (SCr) was 6.25 mg/dL, serum proteins was 6.1 g/dL, albumin/globulin was 4.0/2.1 and electrolytes and thyroid-stimulating hormone were within normal range. Ultrasonography revealed right kidney 10.3 cm × 3.7 cm and left kidney 9.5 cm × 4.1 cm with bilateral increased echo genicity and altered cortico-medullary differentiation. Chest X-ray was unremarkable. She was subjected to one donor-specific leucocyte transfusion and two peripheral blood stem cell (PBSC) infusions for stimulation of donor-specific clones pre-transplantation. In PBSC, a total of 171 mL cells with CD34 count 0.06 and 7.26 × 10 8 /kg body weight of patient were infused to the patient. No deletion of donor-specific antibodies (DSA) was performed as she was splenectomized. She was transplanted under the cover of anti-B-cell antibody Rituximab 600 mg IV, IV immunoglobulin 10 g × 5 days and methylprednisolone 500 mg × 3 days tapered to 75 mg over 7 days, and it was switched to prednisolone 20 mg/day orally subsequently. The patient was maintained on cyclosporine (CyA) 3 mg/kg BW/day for ITP. Her platelet count was increased to 117,000/ cmm after PBSC infusion, and this was sustained for two weeks. No platelet infusion was administered during the peri-/post-transplant period. She was discharged on the 37 th post-transplant day with SCr 1.1 mg/dL and platelet count 97,000/cmm. She maintained adequate stable graft function with no rejection after 23 months post-transplant, with SCr 1.24 mg/dL and platelet count 40,000/cmm on prednisolone 5 mg/day and CyA 125 mg/day.

ITP is a clinical syndrome with thrombocytopenia manifesting as bleeding tendency, purpura and petechiae. In about 60% of the cases, IgG antibodies are detected against platelet membrane glycoprotein IIb-IIIa or Ib-IX. [1],[2] Platelet coating with IgG renders them susceptible to opsonization and phagocytosis by splenic macrophages. Abnormal T-helper cells reacting with platelet antigens on the surface of antigen-presenting cells provide stimulus for autoantibody production. [3] Maintenance of hemodialysis in chronic ITP is not easy because of the difficulty in creating and maintaining arteriovenous fistula, extravasation and hematomas complicating vascular access. We believe that spleen is the major organ for effector humoral responses, and splenectomy in our patient unburdened the memory reservoir response, which rendered transplantation with minimum immunosuppression safe and effective.

ITP with CKD is an uncommon entity. Renal transplantation with minimum immunosuppression in ITP post-splenectomy is safe and effective.

 
   References Top

1.Coopamah M, Garvey M, Freedman J, Semple J. Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update. Transfus Med Rev 2003;17:69-80.  Back to cited text no. 1
    
2.Schwartz RS. Immune thrombocytopenic purpura-from agony to agonist. N Engl J Med 2007;357:2299-301.  Back to cited text no. 2
    
3.Semple JW, Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. Blood 1991; 78:2619-25.  Back to cited text no. 3
    

Top
Correspondence Address:
Kamal V Kanodia
Department of Pathology, Laboratory Medicine, Transfusion Services and Immunohematology, Dr H L Trivedi Institute Of Transplantation Sciences (ITS)-Smt Gulabben Rasiklal Doshi and Smt Kamlaben Mafatlal Mehta Institute off Kidney Diseases and Research Centre (IKDRC), Civil Hospital Campus, Asarwa, Ahmedabad - 380 016, Gujarat
India
Login to access the Email id


DOI: 10.4103/1319-2442.113890

PMID: 23816733

Rights and Permissions




 

Top
   
 
 
    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
    Email Alert *
    Add to My List *
* Registration required (free)  
 


 
    References
 

 Article Access Statistics
    Viewed1316    
    Printed22    
    Emailed0    
    PDF Downloaded287    
    Comments [Add]    

Recommend this journal